These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29369484)

  • 1. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
    Alexander N; Sullivan K; Shaikh F; Irwin MS
    Pediatr Blood Cancer; 2018 May; 65(5):e26964. PubMed ID: 29369484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
    Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
    J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
    Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
    Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed.
    Decarolis B; Simon T; Krug B; Leuschner I; Vokuhl C; Kaatsch P; von Schweinitz D; Klingebiel T; Mueller I; Schweigerer L; Berthold F; Hero B
    BMC Cancer; 2016 Jul; 16():542. PubMed ID: 27465021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed.
    Yang T; Huang Y; Xu T; Tan T; Yang J; Pan J; Hu C; Li J; Zou Y
    Pediatr Surg Int; 2017 Sep; 33(9):955-959. PubMed ID: 28608056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
    Wen Y; Peng Y; Duan XM; Zhang N
    J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathologic features of peripheral neuroblastic tumors].
    Yang BF; Fu LB; He LJ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):305-10. PubMed ID: 24004586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective study of childhood ganglioneuroma.
    De Bernardi B; Gambini C; Haupt R; Granata C; Rizzo A; Conte M; Tonini GP; Bianchi M; Giuliano M; Luksch R; Prete A; Viscardi E; Garaventa A; Sementa AR; Bruzzi P; Angelini P
    J Clin Oncol; 2008 Apr; 26(10):1710-6. PubMed ID: 18375900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and surgical outcome differences on the basis of pathology category in cervical neuroblastic tumors.
    Liu Q; Wang S; Chu P; Sun J; Jin Y; Guo Y; Ma X; He L; Su Y; Zhang J; Peng Y; Li Y; Zhang X; Sun N; Liu Z; Ni X
    J Pediatr Surg; 2022 Dec; 57(12):926-933. PubMed ID: 35961818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
    Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
    Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between typing of peripheral neuroblastic tumors and prognosis: a clinicopathologic study of 135 cases].
    YIN MZ; ZHANG ZD; MA J; SHEN P; CHEN JF; ZHANG HZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):151-5. PubMed ID: 21575383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
    Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
    Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
    Neubauer H; Li M; Müller VR; Pabst T; Beer M
    Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
    [No Abstract]   [Full Text] [Related]  

  • 14. Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
    Wu W; Xu WJ; Liu JB; Sun J; Huang YM; Lv ZB
    Math Biosci Eng; 2019 Aug; 16(6):7217-7229. PubMed ID: 31698611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
    Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
    J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.
    Wang H; Chen X; Yu W; Xie M; Zhang L; Ding H; Li T; Qin J; He L
    Abdom Radiol (NY); 2023 Apr; 48(4):1372-1382. PubMed ID: 36892608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal masses in children: Imaging, surgical treatment and outcome.
    Emre Ş; Özcan R; Bakır AC; Kuruğoğlu S; Çomunoğlu N; Şen HS; Celkan T; Tekant GT
    Asian J Surg; 2020 Jan; 43(1):207-212. PubMed ID: 30962018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The International Neuroblastoma Pathology Classification (the Shimada system).
    Shimada H; Ambros IM; Dehner LP; Hata J; Joshi VV; Roald B; Stram DO; Gerbing RB; Lukens JN; Matthay KK; Castleberry RP
    Cancer; 1999 Jul; 86(2):364-72. PubMed ID: 10421273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective accuracy analysis of MRI based lesion size measurement in neuroblastic tumors: which sequence should we choose?
    Gassenmaier S; Tsiflikas I; Maennlin S; Urla C; Warmann SW; Schaefer JF
    BMC Med Imaging; 2020 Sep; 20(1):105. PubMed ID: 32912148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors.
    Maitra A; Yashima K; Rathi A; Timmons CF; Rogers BB; Shay JW; Gazdar AF
    Cancer; 1999 Feb; 85(3):741-9. PubMed ID: 10091748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.